News
Innovation: A New Look
One of the most overused words in the business lexicon is often misunderstood: What is true innovation? Should it be a priority for all companies? And how can firms make it happen?
News
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
News
New Finance Minister To Stabilize Singapore
Thepublic face of Singapore’s largely successful Covid-19 response is now in charge of the finance ministry.
Economics, Policy & Regulation
Ransomware Attack Births Reporting Mandate
A recent spate of ransomware attacks on U.S. companies has sparked new regulations.
News
Remote Work Heightens Digital Security Issues
Almost half of the North American organizations polled have suffered a data breach via a third party in the past 12 months.
News
UAE Liberalizes Corporate Ownership
The UAE, led by Dubai, earlier created a number of offshore business parks dubbed “free zones,” which permit 100% foreign ownership.
News
Union Rep Becomes First Woman On VW Board
The daughter of an immigrant, union leaderDaniela Cavallo ascends to a leadership position within the German automaker's corporate structure.
News
Bank Of Russia Prepares For Digital Ruble Launch
The Bank of Russia’s announcement is the latest move by central banks to harness the advantages of distributed ledger technology to stave off the rapid ascendancy of competing but regulatory-light cryptocurrencies like Bitcoin and Ethereum.
News
Credit Suisse: Rectifying The Situation
Credit Suisse’s new chairman will have to bring the turn-around skills he utilized at Lloyds a decade ago.
News
Czechs Return To EBRD
The Czech Republic’s decision to rejoin EBRD has an echo of Cyprus belatedly becoming a member country in 2014 in the wake of its financial crisis.
News
Decarbonizing Crypto
The impact of cryptocurrencies on the environment is growing in tandem with its acceptance by mainstream financial institutions.
News
Egypt Opens Massive New Pharmaceuticals Facility
Gypto Pharma City will start by producing Covid-19-related medication and treatments for chronic illnesses such as diabetes, hypertension and heart disease.